Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/30/2010WO2010109015A1 Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization
09/30/2010WO2010109008A1 Prodrugs of substituted 3-(4-hydroxyphenyl)-indolin-2-ones
09/30/2010WO2010109005A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/30/2010WO2010108934A1 Pharmaceutical composition containing a drug and sirna
09/30/2010WO2010108931A1 Combination of an oncolytic adenovirus and a calcium channel blocker and its use for the treatment of cancer
09/30/2010WO2010108921A1 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108855A1 5-β, 14-β-ANDROSTANE DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEINURIA, GLOMERULOSCLEROSIS AND RENAL FAILURE
09/30/2010WO2010108845A1 Pharmaceutical composition containing levodopa, entacapone and carbidopa
09/30/2010WO2010108843A1 Use of nitrooxyderivative of paracetamol for the treatment of muscular dystrophies
09/30/2010WO2010108652A1 Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
09/30/2010WO2010108651A1 Substituted spiro-amide compounds
09/30/2010WO2010108608A1 Substituted piperidines as par-1 antagonists
09/30/2010WO2010108584A1 Synthesis of n-substituted furan-2(5h)-ones
09/30/2010WO2010108553A1 Compositions and pharmaceutical forms for the oral administration of thyroid hormones able to combat the action of sequestrants in the gastrointestinal tract
09/30/2010WO2010108417A1 Method for preparing acyclovir 2/3 hydrate
09/30/2010WO2010108410A1 Use of catechin in preparation of retrovirus integrase inhibitor
09/30/2010WO2010108408A1 Composition of traditional chinese medicine for reducing blood fat and preparation method thereof
09/30/2010WO2010108314A1 Use of fiber pentose or composition containing fiber pentose in manufacture of foods or medicines for preventing and/or treating acidification in diabetic patient
09/30/2010WO2010108277A1 Method for increasing concentration of avenanthramides in oats
09/30/2010WO2010108268A1 Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010WO2010108210A1 Radiolabeled fluorine derivatives of methionine
09/30/2010WO2010093263A8 Compositions and methods for the treatment and prevention of neoplastic disorders
09/30/2010WO2010091308A3 Oligomeric compounds and methods
09/30/2010WO2010091277A3 Solid state forms of aliskiren compounds
09/30/2010WO2010091185A3 Inhibitors of fructose 1,6-bisphosphatase and methods of use thereof
09/30/2010WO2010090969A4 Tetrahydropyran nucleic acid analogs
09/30/2010WO2010089510A3 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
09/30/2010WO2010088457A3 Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase i inhibitors
09/30/2010WO2010086746A3 Compositions and methods of treating viral infections
09/30/2010WO2010086331A3 Composition comprising caftaric acid and/or derivatives thereof
09/30/2010WO2010085924A3 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
09/30/2010WO2010079431A3 Compounds for the prevention and treatment of cardiovascular disease
09/30/2010WO2010078449A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
09/30/2010WO2010077852A3 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
09/30/2010WO2010075418A3 Glyceollins suppress androgen-responsive prostate cancer
09/30/2010WO2010075376A3 Anti-viral compounds
09/30/2010WO2010075090A3 Scopine modulators of muscarinic acetylcholine receptor
09/30/2010WO2010071320A3 Controlled-release composition for producing sustained-release preparation containing udenafil
09/30/2010WO2010068714A3 Deuterated compounds as hepatitis c virus (hcv) inhibitors
09/30/2010WO2010068710A3 Kinase inhibitor compounds
09/30/2010WO2010068483A3 Mlk inhibitors and methods of use
09/30/2010WO2010065671A3 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/30/2010WO2010065662A3 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
09/30/2010WO2010065491A3 Methods of treating inflammatory disorders
09/30/2010WO2010064806A3 Composition for preventing adhesion
09/30/2010WO2010064792A3 Pharmaceutical compositions containing fucoidan for stimulating and activating osteogenesis
09/30/2010WO2010062821A8 Anti-viral compounds, compositions, and methods of use
09/30/2010WO2010056919A3 Eflornithine prodrugs, conjugates and salts, and methods of use thereof
09/30/2010WO2010046273A3 Pyrimidinyl pyridone inhibitors of jnk
09/30/2010WO2010034011A9 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
09/30/2010WO2010025011A8 Formulations of canfosfamide and their preparation
09/30/2010WO2010017626A9 Compositions comprising terpene compounds for treating negative sensory phenomena
09/30/2010WO2010008831A3 Compounds and methods for modulating g protein-coupled receptors
09/30/2010WO2010003022A8 Isoindolone derivatives as mek kinase inhibitors and methods of use
09/30/2010WO2009139504A3 A solid pharmaceutical formulation
09/30/2010WO2009127949A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
09/30/2010WO2009111676A8 Boron-containing small molecules as anti-inflammatory agents
09/30/2010WO2008013925A4 Fungicidal azocyclic amides
09/30/2010WO2007112366A3 Animal product enrichment using resveratrol
09/30/2010US20100251397 Polyploid castor plants, compositions derived therefrom and uses of same
09/30/2010US20100249747 Transdermal venous access locking solution
09/30/2010US20100249746 Drug delivery system for accelerated subcutaneous absorption
09/30/2010US20100249459 Formoterol Tartrate Process and Polymorph
09/30/2010US20100249421 Biphenyl compounds useful as muscarinic receptor antagonists
09/30/2010US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide
09/30/2010US20100249248 LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs)
09/30/2010US20100249247 Antimicrobial compositions
09/30/2010US20100249246 Therapeutic Compounds
09/30/2010US20100249244 Methods and compositions for treating dermatological diseases and conditions
09/30/2010US20100249243 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity
09/30/2010US20100249242 Method of reducing neuronal cell damage
09/30/2010US20100249241 N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
09/30/2010US20100249240 Synergistic mixed poloxamer systems for the solubilisation of drugs
09/30/2010US20100249239 Bis(thio-hydrazide amide) formulation
09/30/2010US20100249238 Pharmaceutical compositions comprising semicarbazones and thiosemicarbazones and method for treating inflammatory, painful and febrile conditions and preventing signs and symptoms of inflammation
09/30/2010US20100249237 Non-Steroidal Anti-Inflammatory Drug Dosing Regimen
09/30/2010US20100249236 Adhesive and plaster
09/30/2010US20100249235 Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
09/30/2010US20100249234 Methods of reducing virulence in bacteria
09/30/2010US20100249233 Compound and use thereof in the treatment of amyloidosis
09/30/2010US20100249231 HSP90 Inhibitors of Protein-Protein Interaction HSP90 Chaperone Complexes and Therapeutic Uses Thereof
09/30/2010US20100249230 Antiviral activity of cyclopentene nitro-ester and derivatives
09/30/2010US20100249229 BICYCLIC gamma-AMINO ACID DERIVATIVE
09/30/2010US20100249228 Sarms and method of use thereof
09/30/2010US20100249226 Tumor selective and biodegradable cyclotriphosphazene-platinum(ii) conjugate anticancer agent, and preparation method thereof
09/30/2010US20100249225 C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for the Treatment of Anxiety Disorders
09/30/2010US20100249224 Methods and compositions for modulating glutamate dehydrogenase
09/30/2010US20100249223 New use for cannabinoid-containing plant extracts
09/30/2010US20100249222 Methods of treating skin with aromatic skin-active ingredients
09/30/2010US20100249221 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
09/30/2010US20100249220 Coumermycin/novobicin-regulated gene expression system
09/30/2010US20100249219 Short rna antagonist compounds for the modulation of hif-1alpha
09/30/2010US20100249218 Method to inhibit cell growth using oligonucleotides
09/30/2010US20100249217 Modulators of pharmacological agents
09/30/2010US20100249216 Method for the production of a cell and/or tissue and/or disease phase specific medicament
09/30/2010US20100249215 Oligomeric Compounds And Compositions For Use In Modulation Of Pri-miRNAs
09/30/2010US20100249214 Multiplex dicer substrate rna interference molecules having joining sequences
09/30/2010US20100249213 MicroRNA Signatures in Human Ovarian Cancer
1 ... 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 ... 7860